Literature DB >> 29614699

Substantia Nigra Echogenicity Associated with Clinical Subtypes of Parkinson's Disease.

Hai-Yan Zhou1, Pei Huang1, Qian Sun1, Juan-Juan Du1, Shi-Shuang Cui1, Yu-Yan Tan1, Yun-Yun Hu2, Wei-Wei Zhan2, Ying Wang1, Qin Xiao1, Jun Liu1, Sheng-Di Chen1.   

Abstract

BACKGROUND: It is debatable whether transcranial sonography (TCS) could be a biomarker for monitoring disease progression. Various phenotypes of Parkinson's disease (PD) may be a major reason contributing to the inconsistency.
OBJECTIVE: We classified PD patients into different subtypes and evaluated the correlation between SN echogenicity and disease progression.
METHODS: A total of 411 PD patients were included in this study. TCS evaluations of the substantia nigra (SN) were performed, and motor and non-motor symptoms were assessed by a series of rating scales in all PD patients.
RESULTS: Three hundred and thirteen patients had appropriate temporal acoustic bone windows, and they were divided into three subgroups according to disease onset age. SN hyperechogenicity (SN+) was found to be associated with age, gender, disease duration, H-Y stage and UPDRS-II scores in 220 middle-age onset patients. Regression analysis identified both disease duration and gender as independent predictors for SN+. When this distinct group was separated into male and female subgroups, the correlation between larger SN echogenicity (SNL) and disease duration was positive in males rather than females. When these middle-age onset male patients were classified as tremor dominant (TD) and non-TD subtypes, it turned out that correlation between disease duration and SNL only existed in male non-TD PD patients.
CONCLUSIONS: Our study demonstrated correlation between the size of SN echogenicity and disease duration in Chinese patients with PD who were male non-TD subtypes with middle-age onset, suggesting the formation of SN echogenicity might be a dynamic process following disease progression in this distinct subtype.

Entities:  

Keywords:  Clinical subtype; Parkinson’s disease; disease severity; substantia zzm321990nigra; transcranial sonography

Mesh:

Year:  2018        PMID: 29614699     DOI: 10.3233/JPD-171264

Source DB:  PubMed          Journal:  J Parkinsons Dis        ISSN: 1877-7171            Impact factor:   5.568


  3 in total

1.  Clinical Features in Parkinson's Disease Patients with Hyperechogenicity in Substantia Nigra: A Cross-Sectional Study.

Authors:  Sha Zhu; Yaxi Wang; Yinyin Jiang; Ruxin Gu; Min Zhong; Xu Jiang; Bo Shen; Jun Zhu; Jun Yan; Yang Pan; Li Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2022-08-02       Impact factor: 2.989

2.  The role of substantia nigra sonography in the differentiation of Parkinson's disease and multiple system atrophy.

Authors:  Hai-Yan Zhou; Pei Huang; Qian Sun; Juan-Juan Du; Shi-Shuang Cui; Yun-Yun Hu; Wei-Wei Zhan; Ying Wang; Qin Xiao; Jun Liu; Yu-Yan Tan; Sheng-Di Chen
Journal:  Transl Neurodegener       Date:  2018-07-23       Impact factor: 8.014

3.  Hypoechogenicity of the midbrain raphe detected by transcranial sonography: an imaging biomarker for depression in migraine patients.

Authors:  YiShui Zhang; Ying Liu; Ruoyun Han; Kangding Liu; Yingqi Xing
Journal:  Ther Adv Neurol Disord       Date:  2021-04-12       Impact factor: 6.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.